Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Lipid-lowering agent-2
Cat. No.:
OB0425LY-232
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Lipid-lowering agent-2 is a class of drugs that are primarily used to lower blood cholesterol and triglyceride levels.
Synonyms:
Lipid-lowering agent-2; Lipid-lowering agent 2
Formula:
C25H27N7O
Formula Weight:
441.53
Specification
Target:
AMPK
Pathway:
Epigenetics; PI3K/Akt/mTOR
Storage:
Storage at -20°C.
Applications:
Lipid-lowering agent-2 is commonly used in hyperlipidemia studies to control lipid levels.
